Ratings AB&Company Co.,Ltd.

Equities

9251

JP3160630004

Delayed Japan Exchange Other stock markets 01:20:01 02/05/2024 BST			5-day change	1st Jan Change
897 ^JPY	+0.45%		0.00%	-3.44%

2023	Tranche Update on AB&Company Co., Ltd.'s Equity Buyback Plan announced on October 2, 2023.	CI
2023	AB&Company Co., Ltd.'s Equity Buyback announced on October 2, 2023, has closed with 1,000,000 shares, representing 6.62% for ¥996.06 million.	CI

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

With a P/E ratio at 11.07 for the current year and 9.57 for next year, earnings multiples are highly attractive compared with competitors.
The group usually releases upbeat results with huge surprise rates.

Ratings chart - Surperformance

Sector: Personal Services

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
AB&COMPANY CO.,LTD.	-3.44%	80M		-
EUROPEAN WAX CENTER, INC.	-13.39%	572M		D+
BEAUTY FARM MEDICAL AND HEALTH INDUSTRY INC.	+46.75%	490M		-
SIAM WELLNESS GROUP	+6.68%	285M		-
EC HEALTHCARE	-24.71%	199M		-
QB NET HOLDINGS CO.,LTD.	-24.13%	95.07M		-
MPM CORPÓREOS S.A.	-20.49%	64.95M		-
MIRICOR ENTERPRISES HOLDINGS LIMITED	-15.86%	62.39M	-	-
MU GLOBAL HOLDING LIMITED	-.--%	61.81M	-	-
DC HEALTHCARE HOLDINGS	-32.10%	57.46M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes